6/1/2023 0 Comments Pure Blood 1 by Akane Aoki![]() Amb4269951 is the lead compound in the treatment of glioma and exhibits a novel therapeutic mechanism. Finally, Amb4269951 demonstrated an antitumor effect in a mice xenograft model by significantly inhibiting tumor growth without any weight loss. CTL1-mediated choline uptake is associated with cell viability, and the functional inhibition of CTL1 by Amb4269951 may promote apoptotic cell death via ceramide-induced suppression of the expression of survivin, an apoptotic inhibitory factor. Amb4269951 inhibited choline uptake and cell viability and increased caspase-3/7 activity. Here, we investigated the therapeutic mechanism underlying the antitumor effects of Amb4269951, a recently discovered novel CTL1 inhibitor, in the human glioma cell line U251MG, and evaluated its in vivo effects in a mouse xenograft model. Therefore, CTL1 is a potential target molecule for glioma therapy. ![]() Choline transporter-like protein 1 (CTL1) is highly expressed in glioma cells, and inhibition of CTL1 function induces apoptotic cell death. ![]()
0 Comments
Leave a Reply. |